Himalaya Therapeutics
Dr. Padmanee Sharma is a professor of Genitourinary Medical Oncology and Immunology in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. She has participated in 54 research outputs since 1996, focusing primarily on immunotherapy in her collaborations with Dr. James P. Allison. Sharma is a Cancer Research Institute Investigator who has tested new prostate cancer immunotherapies, looking for differences in T cell subsets and function between pre-therapy blood and tissue samples versus post-therapy blood and tissue samples. She has won multiple awards during her career including the 2012 MD Anderson Cancer Center Faculty Scholar Award and the 2008 Melanoma Research Alliance Young Investigator Award. With Allison, Sharma is exploring combinations of immunological therapies and targeted drugs in preclinical studies to more effectively treat a variety of cancers.
This person is not in the org chart
This person is not in any offices
Himalaya Therapeutics
Himalaya is a majority owned subsidiary of BioAtla, Inc. and a Cayman Island corporation. Himalaya has the exclusive license from BioAtla to develop and commercialize several specific CAB candidates for the Greater China market of the PRC,